Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market

Relay Therapeutics (RLAY) Technical Analysis

324 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Relay Therapeutics’s (RLAY) Moving Averages Convergence Divergence (MACD) indicator is 0.58, suggesting Relay Therapeutics is a Sell.
Relay Therapeutics’s (RLAY) 20-Day exponential moving average is 8.19, while Relay Therapeutics’s (RLAY) share price is $8.94, making it a Buy.
Relay Therapeutics’s (RLAY) 50-Day exponential moving average is 7.64, while Relay Therapeutics’s (RLAY) share price is $8.94, making it a Buy.

Relay Therapeutics (RLAY) Pivot Points

Jul 28, 2024, 11:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
7.84
8.31
8.68
9.16
9.53
10.00
10.38
Fibonacci
8.31
8.63
8.83
9.16
9.48
9.68
10.00
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Relay Therapeutics (RLAY) Moving Averages

Jul 28, 2024, 11:04 AM
Period
Simple
Exponential
MA5
9.04Sell
8.95Sell
MA10
8.86Buy
8.70Buy
MA20
7.85Buy
8.19Buy
MA50
7.33Buy
7.64Buy
MA100
7.36Buy
7.72Buy
MA200
8.28Buy
8.33Buy
Relay Therapeutics’s (RLAY) 10-Day exponential moving average is 8.70, while Relay Therapeutics’s (RLAY) share price is $8.94, making it a Buy.
Relay Therapeutics’s (RLAY) 100-Day exponential moving average is 7.72, while Relay Therapeutics’s (RLAY) share price is $8.94, making it a Buy.
Relay Therapeutics’s (RLAY) stock price is $8.94 and Relay Therapeutics’s (RLAY) 50-day simple moving average is 7.33, creating a Buy signal.
Relay Therapeutics’s (RLAY) stock price is $8.94 and Relay Therapeutics’s (RLAY) 100-day simple moving average is 7.36, creating a Buy signal.
Relay Therapeutics’s (RLAY) stock price is $8.94 and Relay Therapeutics’s (RLAY) 200-day simple moving average is 8.28, creating a Buy signal.

Relay Therapeutics (RLAY) Technical Indicators

Jul 28, 2024, 11:04 AM
Name
Value
Implied Action
RSI (14)
63.74
Neutral
STOCH (9,6)
53.38
Neutral
STOCHRSI (14)
77.46
Neutral
MACD (12,26)
0.58
Sell
ADX (14)
35.20
Neutral
Williams %R
-24.41
Buy
CCI (14)
70.36
Neutral
ATR (14)
0.61
-
Ultimate Oscillator
50.87
Neutral
ROC
37.96
Buy
Relay Therapeutics’s (RLAY) Relative Strength Index (RSI) is 63.74, creating a Neutral signal.
Relay Therapeutics’s (RLAY) Trend Strength Indicator (ADX) is 35.20, creating a Neutral signal.
Relay Therapeutics’s (RLAY) Commodity Channel Index (CCI) is 70.36, creating a Neutral signal.
Relay Therapeutics’s (RLAY) Price Rate of Change (ROC) is 37.96, creating a Buy signal.

FAQ

Is RLAY a Buy, Hold, or Sell?
Based on RLAY’s technical indicators, RLAY is a Buy.
    What is RLAY’s RSI (14)?
    RLAY’s RSI (14) is 63.74, which suggests RLAY is a Neutral.
      What is RLAY’s MACD?
      RLAY’s MACD is 0.58, which suggests RLAY is a Sell.
        What is RLAY’s 5-day moving average?
        RLAY’s 5-day moving average is 9.04, which suggests RLAY is a Sell.
          What is RLAY’s 20-day moving average?
          RLAY 20-day moving average is 7.85, which suggests RLAY is a Buy.
            What is RLAY’s 50-day moving average?
            RLAY’s 50-day moving average is 7.33, which suggests RLAY is a Buy.
              What is RLAY’s 200-day moving average?
              RLAY’s 200-day moving average is 8.28, which suggests RLAY is a Buy.
                What is RLAY’s Williams % R (14)?
                RLAY’s Williams % R (14) is -24.41, which suggests RLAY is a Buy.
                  What is RLAY’s CCI (14)?
                  RLAY’s CCI (14) is 70.36, which suggests RLAY is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis